Boosting CD39 expression either by inducing AhR-signaling or by administering exogenous ADPase, which displays ectoenzymatic activity comparable to human CD39, showed important immunoregulatory effects in vitro and in vivo, in experimental colitis models. Here, ENTPD1 is linked to colitis.